These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17429429)

  • 21. T cell receptor genotyping and HOXA/TLX1 expression define three T lymphoblastic lymphoma subsets which might affect clinical outcome.
    Baleydier F; Decouvelaere AV; Bergeron J; Gaulard P; Canioni D; Bertrand Y; Lepretre S; Petit B; Dombret H; Beldjord K; Molina T; Asnafi V; Macintyre E
    Clin Cancer Res; 2008 Feb; 14(3):692-700. PubMed ID: 18245528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three cases of primary cutaneous lymphoblastic lymphoma: microarray-based comparative genomic hybridization and gene expression profiling studies with review of literature.
    Vezzoli P; Novara F; Fanoni D; Gambini D; Balice Y; Venegoni L; Paulli M; Crosti C; Berti E
    Leuk Lymphoma; 2012 Oct; 53(10):1978-87. PubMed ID: 21879810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression profiling of murine T-cell lymphoblastic lymphoma identifies deregulation of S-phase initiating genes.
    Dabrowska MJ; Ejegod D; Lassen LB; Johnsen HE; Wabl M; Pedersen FS; Dybkær K
    Leuk Res; 2013 Oct; 37(10):1383-90. PubMed ID: 23896059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphoblastic lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression.
    Herblot S; Steff AM; Hugo P; Aplan PD; Hoang T
    Nat Immunol; 2000 Aug; 1(2):138-44. PubMed ID: 11248806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.
    Aplan PD; Jones CA; Chervinsky DS; Zhao X; Ellsworth M; Wu C; McGuire EA; Gross KW
    EMBO J; 1997 May; 16(9):2408-19. PubMed ID: 9171354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms.
    Eißmann M; Melzer IM; Fernández SB; Michel G; Hrabě de Angelis M; Hoefler G; Finkenwirth P; Jauch A; Schoell B; Grez M; Schmidt M; Bartholomae CC; Newrzela S; Haetscher N; Rieger MA; Zachskorn C; Mittelbronn M; Zörnig M
    Oncogene; 2013 May; 32(20):2586-91. PubMed ID: 22751129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
    Curtis DJ; Robb L; Strasser A; Begley CG
    Oncogene; 1997 Dec; 15(24):2975-83. PubMed ID: 9416841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unexpected features of acute T lymphoblastic lymphomas in Notch1IC transgenic rats.
    van den Brandt J; Kwon SH; McPherson KG; Petrovic S; Zettl A; Müller-Hermelink HK; Reichardt HM
    Eur J Immunol; 2006 Aug; 36(8):2223-34. PubMed ID: 16838279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conditional expression and oncogenicity of c-myc linked to a CD2 gene dominant control region.
    Stewart M; Cameron E; Campbell M; McFarlane R; Toth S; Lang K; Onions D; Neil JC
    Int J Cancer; 1993 Apr; 53(6):1023-30. PubMed ID: 8473043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha 4 beta 7 integrin expression is associated with the leukemic evolution of human and murine T-cell lymphoblastic lymphomas.
    Dolcetti R; Giardini R; Doglioni C; Cariati R; Pomponi F; D'Orazi C; Rao S; Lazarovits AI; Butcher EC; Boiocchi M
    Am J Pathol; 1997 May; 150(5):1595-605. PubMed ID: 9137086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
    Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
    Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-cell lymphoblastic lymphoma shows differences and similarities with T-cell acute lymphoblastic leukemia by genomic and gene expression analyses.
    Basso K; Mussolin L; Lettieri A; Brahmachary M; Lim WK; Califano A; Basso G; Biondi A; Cazzaniga G; Rosolen A
    Genes Chromosomes Cancer; 2011 Dec; 50(12):1063-75. PubMed ID: 21987448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia.
    Sun L; Goodman PA; Wood CM; Crotty ML; Sensel M; Sather H; Navara C; Nachman J; Steinherz PG; Gaynon PS; Seibel N; Vassilev A; Juran BD; Reaman GH; Uckun FM
    J Clin Oncol; 1999 Dec; 17(12):3753-66. PubMed ID: 10577847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FoxN1-dependent thymic epithelial cells promote T-cell leukemia development.
    Ghezzo MN; Fernandes MT; Pacheco-Leyva I; Rodrigues PM; Machado RS; Araújo MAS; Kalathur RK; Futschik ME; Alves NL; Dos Santos NR
    Carcinogenesis; 2018 Dec; 39(12):1463-1476. PubMed ID: 30256907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of ABL1 expression in adult T-cell acute lymphoblastic leukemia by oligonucleotide array analysis.
    Chiaretti S; Tavolaro S; Ghia EM; Ariola C; Matteucci C; Elia L; Maggio R; Messina M; Ricciardi MR; Vitale A; Ritz J; Mecucci C; Guarini A; Foà R
    Haematologica; 2007 May; 92(5):619-26. PubMed ID: 17488685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.
    Raetz EA; Perkins SL; Bhojwani D; Smock K; Philip M; Carroll WL; Min DJ
    Pediatr Blood Cancer; 2006 Aug; 47(2):130-40. PubMed ID: 16358311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations.
    Andersson A; Edén P; Lindgren D; Nilsson J; Lassen C; Heldrup J; Fontes M; Borg A; Mitelman F; Johansson B; Höglund M; Fioretos T
    Leukemia; 2005 Jun; 19(6):1042-50. PubMed ID: 15843827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous involvement in lymphoblastic lymphoma.
    Chimenti S; Fink-Puches R; Peris K; Pescarmona E; Pütz B; Kerl H; Cerroni L
    J Cutan Pathol; 1999 Sep; 26(8):379-85. PubMed ID: 10551409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Transgenic mice expressing MTCP1: an animal model for T-cell prolymphocytic leukemia].
    Chiali-Gritti C
    Ann Pharm Fr; 2000 Jan; 58(1):54-61. PubMed ID: 10669814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.